Clinical Trial

A Study of DS-3939a in Participants With Solid Tumors

Name: A Study of DS-3939a in Participants With Solid Tumors — clinical trial record (NCT07739966)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The primary purpose of the study is to evaluate the safety, tolerability, and efficacy of DS-3939a in combination with other anticancer agents or as a monotherapy in participants with solid tumors.

Trial Details

NCT Number	NCT07739966
Lead Sponsor	Daiichi Sankyo
Conditions	Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer
Enrollment	400 participants
Start Date	2026-10-01
Primary Completion	2030-07-31 (estimated)
Study Completion	2032-01-29 (estimated)
Updated on ClinicalTrials.gov	2026-07-31